Intervention

BCG vaccine

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting0

Common conditions9

Lead sponsors shown5

Clinical trials

6 shown

Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?NCT06078891 · 2023-07-01

ENROLLING_BY_INVITATION

Bacillus Calmette-guérin Vaccination to Prevent COVID-19NCT04414267 · 2020-05-26

Vaccine Therapy in Treating Patients With Stage D0 Prostate CancerNCT00514072 · 2007-03-01

Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung CancerNCT00006352 · 1999-09-01

Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerNCT00003279 · 1998-03-01

Vaccine Therapy in Treating Women With Metastatic Breast CancerNCT00003184 · 1996-08-01

Common conditions

Lung Cancer2 Alzheimer Disease, Late Onset1 Breast Cancer1 Chronic Obstructive Pulmonary Disease1 Corona Virus Infection1 Coronary Heart Disease1 COVID-191 Prostate Cancer1 Virus Diseases1

Leading sponsors

European Organisation for Research and Treatment of Cancer - EORTC2 Hellenic Institute for the Study of Sepsis1 Kael-GemVax Co., Ltd.1 Providence Cancer Center, Earle A. Chiles Research Institute1 Tamir Ben-Hur1

Trial status mix

COMPLETED4

ENROLLING_BY_INVITATION1

UNKNOWN1

Phase mix

PHASE32

EARLY_PHASE11

PHASE11

PHASE21

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.